{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T13:19:58Z","timestamp":1788527998266,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbrc.2026.154387","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:30:47Z","timestamp":1785799847000},"page":"154387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["USP33-mediated deubiquitination stabilizes YTHDF2 and promotes glioblastoma malignancy and temozolomide resistance"],"prefix":"10.1016","volume":"833","author":[{"given":"Shaoshan","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongliao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154387_bib1","first-page":"299","article-title":"Management of glioblastoma: state of the art and future directions","volume":"70","author":"Tan","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2026.154387_bib2","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s42003-022-03639-8","article-title":"Targeted inhibition of ubiquitin signaling reverses metabolic reprogramming and suppresses glioblastoma growth","volume":"5","author":"Delle Donne","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbrc.2026.154387_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2026.156440","article-title":"Interpreting the ubiquitin signal: deubiquitinating enzymes in cancer and disease","volume":"282","author":"Jamal","year":"2026","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bbrc.2026.154387_bib4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/med.21421","article-title":"Targeting deubiquitinating enzymes in glioblastoma multiforme: expectations and challenges","volume":"37","author":"Jin","year":"2017","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbrc.2026.154387_bib5","article-title":"Exploring the ubiquitin-proteasome system in protein homeostasis and healthy aging using Caenorhabditis elegans as a model: a review","author":"Yuan","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbrc.2026.154387_bib6","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/s41419-025-08266-9","article-title":"USP11 promotes colorectal cancer progression by stabilizing EGFR and TRAF6: a potential therapeutic target in EGFR- and TLR-driven tumorigenesis","volume":"16","author":"Shin","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.154387_bib7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature11941","article-title":"USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110","volume":"495","author":"Li","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154387_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.23736\/S0390-5616.20.04929-2","article-title":"Downregulation of USP33 inhibits slit\/robo signaling pathway and is associated with poor patient survival of glioma","volume":"67","author":"Han","year":"2023","journal-title":"J. Neurosurg. Sci."},{"key":"10.1016\/j.bbrc.2026.154387_bib9","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021109187","article-title":"USP33 deubiquitinates and stabilizes HIF-2alpha to promote hypoxia response in glioma stem cells","volume":"41","author":"Zhang","year":"2022","journal-title":"Embo j"},{"key":"10.1016\/j.bbrc.2026.154387_bib10","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3389\/fphar.2018.01080","article-title":"Inhibition of ubiquitin-specific proteases as a novel anticancer therapeutic strategy","volume":"9","author":"Yuan","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154387_bib11","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1038\/s41418-019-0473-8","article-title":"Deubiquitinating enzyme USP33 restrains docetaxel-induced apoptosis via stabilising the phosphatase DUSP1 in prostate cancer","volume":"27","author":"Guo","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbrc.2026.154387_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27041967","article-title":"m(6)A RNA methylation is increased in tumour invasive regions and influences invasive capability and chemotherapeutic sensitivity in adult glioblastoma","volume":"27","author":"Radhi","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154387_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/biof.70099","article-title":"Mechanism of YTHDF2-Mediated epigenetic modification in the proliferation and invasion of renal cell carcinoma cells","volume":"52","author":"Zhang","year":"2026","journal-title":"Biofactors"},{"key":"10.1016\/j.bbrc.2026.154387_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-026-03684-9","article-title":"RBM15 drives bladder cancer progression through YTHDF2-dependent m6A-mediated regulation of ZO2","volume":"45","author":"He","year":"2026","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154387_bib15","article-title":"GDPPH1 induces cell cycle arrest by downregulation of CDK4\/Cyclin D1 via the m(6)A-METTL14-YTHDF2 axis, attenuating glioblastoma progression","author":"Li","year":"2026","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.154387_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1393","article-title":"YTHDF2 promotes temozolomide resistance in glioblastoma by activation of the akt and NF-\u03baB signalling pathways via inhibiting EPHB3 and TNFAIP3","volume":"11","author":"Chen","year":"2022","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.bbrc.2026.154387_bib17","doi-asserted-by":"crossref","first-page":"7774","DOI":"10.18632\/aging.204104","article-title":"DNA methylation-regulated YTHDF2 correlates with cell migration and immune cell infiltration in glioma","volume":"14","author":"Jiang","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbrc.2026.154387_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107152","article-title":"YTHDF2 protein stabilization by the deubiquitinase OTUB1 promotes prostate cancer cell proliferation via PRSS8 mRNA degradation","volume":"300","author":"Zhao","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154387_bib19","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/jcmm.17764","article-title":"Apoptotic effect and cell arrest of deoxyshikonin in human osteosarcoma cells through the p38 pathway","volume":"27","author":"Hsieh","year":"2023","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bbrc.2026.154387_bib20","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature11903","article-title":"Corrigendum: comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"494","author":"Network","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154387_bib21","first-page":"A68","article-title":"The cancer genome atlas (TCGA): an immeasurable source of knowledge","volume":"19","author":"Tomczak","year":"2015","journal-title":"Contemp. Oncol."},{"key":"10.1016\/j.bbrc.2026.154387_bib22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2026.154387_bib23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2026.154387_bib24","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1039\/D0SC01347A","article-title":"Engineered unnatural ubiquitin for optimal detection of deubiquitinating enzymes","volume":"11","author":"Rut","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bbrc.2026.154387_bib25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.15407\/exp-oncology.2025.04.395","article-title":"The ubiquitin-proteasome system in cancer: mechanisms, targets and therapeutic potential","volume":"47","author":"Nishchenko","year":"2026","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.bbrc.2026.154387_bib26","article-title":"Decoding m(6)A readers: roles of YTHDF proteins in leukemogenesis and cancer immunity","volume":"16","author":"Li","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.154387_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.112145","article-title":"YTHDF2 drives oral squamous cell carcinoma progression via m(6)A-dependent degradation of MTUS1\/ATIP1 mRNA and mitochondrial dysregulation","volume":"136","author":"Tang","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbrc.2026.154387_bib28","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1080\/14786419.2022.2132499","article-title":"Shikonin derivatives as potent xanthine oxidase inhibitors: in-vitro study","volume":"37","author":"Kumar","year":"2023","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.bbrc.2026.154387_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.bbrc.2026.154387_bib30","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/ijc.29483","article-title":"Shikonin and its derivatives inhibit the epidermal growth factor receptor signaling and synergistically kill glioblastoma cells in combination with erlotinib","volume":"137","author":"Zhao","year":"2015","journal-title":"Int. J. Cancer"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26011514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26011514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:47:38Z","timestamp":1788526058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26011514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":30,"alternative-id":["S0006291X26011514"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154387","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"USP33-mediated deubiquitination stabilizes YTHDF2 and promotes glioblastoma malignancy and temozolomide resistance","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"154387"}}